Chemed Corp (CHE) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.

Total Revenue Chart for Chemed Corp

Chemed Corp (CHE) revenue for FY2025 was USD 2.5B, a 4.1% change from FY2024. Chemed Corp's revenue grew from USD 372.7M in 1985 to USD 2.5B in 2025 (578.8% over 40 years). Earnings per share grew from USD 1.04 in 2000 to USD 18.42 in 2025 (1676.9%). Revenue compound annual growth rate: 5-year CAGR of 4.0%, 10-year CAGR of 5.1%, 20-year CAGR of 5.2%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$6.66B
Implied Share Price
$509.84
Enterprise Value
$6.76B
Revenue (TTM)
$2.60B
EBITDA
$416.92M
Profit Margin
10.60%
Trailing P/E
25.65
Forward P/E
18.18
Price/Book (MRQ)
7.84
Price/Sales (TTM)
2.57
EV/EBITDA
15.41
EV/Revenue
2.61
Dividend Yield
0.47%
Book Value
$63.81
Free Cash Flow (FY2025)
$325.48M
Free Cash Flow Yield
4.88%

Snapshot as of 6th October 2026 — not point-in-time controlled, may lag the live market by a few days.